- Have any questions?
- +44 7884 430482
- info@exymesplc.com
Our Team
Richard Healey, CEO
25 years CEO/leadership experience inc. start-ups to blue-chip multinationals Former CEO of Morgan Crucible Intl division Chairman/Director of number of UK PLC’s and Chair of audit, remuneration and nomination committees Track record of growing companies both organically and by acquisition and listing companies on public markets
Dr David Saul, CSO
40 years experience in molecular genetics and microbiology with further specialties in biotech, computational biology and forensic DNA analysis Generated a lot of eXymes IP and know-how Research included the development of biotechnical applications of microorganisms living in extreme environments.
Assoc Prof Jo Stanton, COO
Specialises in development and implementation of point-of-care and in-field molecular diagnostic technologies Lead investigator on projects giving rise to eXymes PDQeX device. Currently holds positions with the University of Otago, Dunedin and Victoria University Wellington, New Zealand
Malcom Goat, CFO
Experienced CFO and NED, ex-PwC London with experience spanning four decades in international business and public markets. Former CFO of small high growth technology companies and billion-dollar global divisions in two FTSE 250 companies Board member of a fund specializing in bringing entrepreneurial companies to the market.
Dr Stef Hamill, NED
Top ranked life sciences analyst for 20 years: #2 UK healthcare & life sciences analyst in 2022 Built two #1 franchises, Peel Hunt and Numis, that dominated UK life sciences investment banking for over a decade Helped advise, finance, and build billion-dollar-plus life science successes such as Abcam, Oxford Nanopore, Syncona, Oxford Sciences and PureTech
Prof James Landers, NED
Specializes in microscale analytical technology and founded the Clinical Electrophoresis facility at Mayo Clinic Developed 1st integrated microfluidic sample to result genetic analysis Currently professor of Chemistry and Mech Eng and assoc professor of Pathology University of Virginia USA. Professor James Landers is also a world leader at microfluidics and is a visiting professor at Dublin university.
About Team
About eXymes
At eXymes, we’re reimagining the way science approaches nucleic acid extraction. Born from a legacy of Antarctic exploration and powered by extremophile enzymes, our solutions bring simplicity, speed, and sustainability to molecular workflows around the world.
We specialize in temperature-driven, enzyme-based extraction technologies that eliminate the need for harsh chemicals, columns, and complex protocols. Our flagship products—prepGEM and PDQeX—are trusted by scientists, forensic experts, and researchers for their reliability, efficiency, and eco-conscious design.
Whether supporting field-based diagnostics or high-throughput laboratory workflows, eXymes is committed to enabling science that’s faster, cleaner, and smarter.
Investment Opportunity
Invest in eXymes innovative biotechnology solutions driving efficiency, sustainability, and automation in nucleic acid extraction. Join us in advancing the future of scientific discovery.